For MEIP holders., page-20

MEI Pharma, Inc. (MEIP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

3.2300+0.2700 (+9.12%)
At close: 4:00PM EDT



3.2900 +0.06 (1.86%)
After hours: 6:01PM EDT


https://finance.yahoo.com/news/mei-pharma-inc-meip-shares-130901129.html

MEI Pharma, Inc. (MEIP): This late-stage pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
MEI Pharma, Inc. Price and Consensus

MEI Pharma, Inc. Price and Consensus
MEI Pharma, Inc. price-consensus-chart | MEI Pharma, Inc. Quote
MEI Pharma’s shares gained 18.6% over the last one month. The company possesses a Momentum Score of A.
MEI Pharma, Inc. Price

MEI Pharma, Inc. Price
MEI Pharma, Inc. price | MEI Pharma, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

MEI Pharma, Inc. (MEIP) : Free Stock Analysis Report

Kopin Corporation (KOPN) : Free Stock Analysis Report

IIVI Incorporated (IIVI) : Free Stock Analysis Report

Halozyme Therapeutics, Inc. (HALO) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research


Sign in to post a message.



MEI Pharma, Inc. (MEIP) Shares March Higher, Can It Continue?

Zacks Equity Research
,
Zacks•May 15, 2020

MEI Pharma, Inc. (MEIP) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in MEI Pharma, Inc. (MEIP). The stock has moved higher by 27.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider MEIP’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as MEIP has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.